How to · 2026-09-17
Join a trial,
for real.
Trial enrollment is the only lawful way to receive retatrutide. Here is how to search the public registry, what obesity trials screen for, what participation costs you, and the honest truth about placebo arms.
Why this is the only route
Retatrutide is investigational everywhere on earth, so no pharmacy can dispense it and no physician can write a prescription for it. That leaves one lawful way to receive the drug: enrollment in a study that is giving it out. Everything else on the internet that promises retatrutide is an unregulated research chemical, which is the whole argument of our retatrutide guide and the reason the approval tracker still reads not approved.
Start at the registry
Every legitimate study in the United States is listed publicly at clinicaltrials.gov. Search the drug name and you get the entire program, including the studies that finished years ago. Two filters do most of the work. Set status to recruiting, so completed and closed studies drop away. Then set location to your state or a distance from your zip code, because a study can be running nationally and still have no site within a day of you.
The result is usually smaller than people expect. In September 2026 most of the numbered TRIUMPH studies are active but no longer recruiting, meaning the doors are shut even though the trials are running. What is open on retatrutide right now runs mainly through a large master protocol in metabolic dysfunction-associated steatotic liver disease, which has retatrutide as one of several arms and more than a hundred sites across the United States. If nothing on retatrutide fits, widening the search to obesity and to other trial drugs is the move that actually gets people enrolled.
Reading a study page
Each listing has the same anatomy, and four sections matter. Status tells you whether the site is taking people. Eligibility lists inclusion and exclusion criteria in plain lines. Locations names every site, city by city, with a contact. Outcome measures tell you what the study is actually trying to learn, which is how you spot a trial whose real subject is a side question rather than weight.
Read the arms section too. It tells you how many groups there are and what each one receives, which is where you learn your odds of getting the drug rather than a dummy injection. Then call the nearest site directly. The contact on the listing is a research coordinator whose job is exactly this conversation, and a five minute call resolves eligibility faster than an hour of reading.
What screening asks
Obesity trials in this class are built to a familiar pattern. Adults, usually 18 and up. A body mass index of 30 or above, or 27 and above with a weight-related condition such as high blood pressure, abnormal lipids, obstructive sleep apnea or heart disease. Often a documented unsuccessful attempt at losing weight through diet. Willingness to self-inject weekly, to keep a visit schedule and to complete questionnaires.
Screening itself is a medical workup: bloodwork, an electrocardiogram in many protocols, a pregnancy test where relevant, and standardized questionnaires including depression screening. It is thorough because the sponsor needs a clean population, and it is free to the participant.
What rules people out
The exclusions are where most hopeful applicants stop, so know them before you get attached. Recent weight loss drugs are the big one. Trials in this family commonly exclude anyone who has taken a weight loss medication, including over-the-counter products, within 90 days of screening, which means an existing semaglutide or tirzepatide prescription disqualifies you unless you stop long enough in advance. A self-reported weight change of more than 11 pounds in the three months before screening also excludes.
Beyond that: a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, which is a hard stop for this whole drug class. A history of pancreatitis. Prior or planned bariatric surgery. Type 1 or type 2 diabetes in studies designed for people without diabetes, and the reverse in the diabetes studies. A heart attack, stroke or hospitalization for unstable angina or heart failure within the past 90 days. Severe heart failure. Uncontrolled blood pressure. Significant psychiatric instability or a history of suicide attempt. None of this is arbitrary and none of it is negotiable at the site level.
What you get and give
What you get: the study drug at no cost, study visits and lab work at no cost, close medical supervision from people who see this molecule all day, and in many protocols a stipend for time and travel. What you give is real. Randomization decides your arm, not your preference. Visits are frequent and scheduled around the protocol rather than your life. There are diaries, questionnaires and blood draws. You may be asked to keep taking a drug that is making you nauseated while the team decides whether to adjust it. You can withdraw at any time, and a study that suggests otherwise is not one to join.
Say placebo out loud
Placebo-controlled means some participants get inert injections for the length of the study, and in placebo-controlled obesity trials that share can be substantial. If you enroll expecting 24 percent weight loss and draw the placebo arm, you have spent a year of visits on saltwater. Some studies are open-label or compare two active drugs and have no placebo at all, which the arms section states plainly. Ask the coordinator for the exact odds before you consent, because the number varies by study and is never a secret.
Questions for the site
Ask what the randomization ratio is. Ask how long the treatment period runs and what happens when it ends, including whether an extension gives everyone the active drug. Ask who pays if a study procedure finds an unrelated medical problem. Ask what happens to your care if you withdraw early. Ask whether the site is paid per enrolled participant. Good sites answer all five without hesitation, and the informed consent document repeats the answers in writing before you sign anything.
If nothing fits
Most people who search for a retatrutide trial are not looking for research, they are looking for the drug. If that is the honest version, the faster path is a licensed physician and an approved medicine that exists today, which is what the doctor route lays out. Waiting for retatrutide costs nothing. Buying a gray vial while you wait costs a great deal.